LivingGLP1
Study S001261

Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon

Registration

Registration
NCT02417103
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE3
Masking
DOUBLE
Status
TERMINATED
Enrollment
2
Start
2011-12
Primary completion
2016-09
Lead sponsor
Universitätsklinikum Hamburg-Eppendorf
Conditions
Obesity
Interventions
DRUG:GLP-1 (Liraglutide); DRUG:Placebo
Results posted
FALSE

Registered primary outcomes

  • weight reduction [4 years]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.